SIREN : 398083790
SELARL DR. AIT-BELKACEM is a French company founded 31 years ago, specialized in the sector Activités vétérinaires. Based in VERT-SAINT-DENIS (77240), this company of category PME shows in 2019 a revenue of 465 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|
| Revenue | 464 788 € | 368 423 € | 457 597 € | 477 596 € | 473 935 € | 338 397 € |
| Net income | 49 161 € | 13 557 € | 52 720 € | 61 220 € | 40 719 € | 31 594 € |
| EBITDA | 62 406 € | 728 € | 81 639 € | 81 324 € | 44 189 € | 39 047 € |
| Net margin | 10.6% | 3.7% | 11.5% | 12.8% | 8.6% | 9.3% |
In 2019, SELARL DR. AIT-BELKACEM achieves revenue of 465 k€. Over the period 2014-2019, the company shows strong growth with a CAGR (compound annual growth rate) of +6.6%. Vs 2018, growth of +26% (368 k€ -> 465 k€). After deducting consumption (120 k€), gross margin stands at 345 k€, i.e. a rate of 74%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 62 k€, representing 13.4% of revenue. Positive scissor effect: EBITDA margin improves by +13.2 pts, sign of improved operational efficiency. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 49 k€, i.e. 10.6% of revenue. This profit can be retained or distributed to shareholders.
464 788 €
344 584 €
62 406 €
59 749 €
49 161 €
13.4%
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 87%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 10.9% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
1.453%
87.464%
10.934%
0.101
20.4%
In 2019, the debt ratio of SELARL DR. AIT-BELKACEM (1.45) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2019, the financial autonomy of SELARL DR. AIT-BELKACEM (87.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2019, the repayment capacity of SELARL DR. AIT-BELKACEM (0.10) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 216.80. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.1x. Danger: operating income does not cover interest charges, unsustainable situation.
216.796
0.066
In 2019, the liquidity ratio of SELARL DR. AIT-BELKACEM (216.80) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2019, the interest coverage of SELARL DR. AIT-BELKACEM (0.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 9 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 18 days. Favorable situation: supplier credit is longer than customer credit by 9 days. Inventory turnover is 18 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 31 days of revenue, i.e. 40 k€ to permanently finance. Over 2014-2019, WCR increased by +26%, requiring additional financing.
40 497 €
9 j
18 j
18 j
31 j
Compare SELARL DR. AIT-BELKACEM with other companies in the same sector:
Voir toutes les statistiques du secteur Activités vétérinaires
The revenue of SELARL DR. AIT-BELKACEM in 2019 is 465 k€.
Yes, SELARL DR. AIT-BELKACEM generated a net profit of 49 k€ in 2019.
The headquarters of SELARL DR. AIT-BELKACEM is located in VERT-SAINT-DENIS (77240), in the department Seine-et-Marne.
The tax return of SELARL DR. AIT-BELKACEM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SELARL DR. AIT-BELKACEM operates in the sector Activités vétérinaires (NAF code 75.00Z). See the 'Sector positioning' section above to compare the company with its competitors.